Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 184
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports 2024 Boscolo Bragadin, AndreaGuarneri, ValentinaBonanno, LauraIndraccolo, Stefano + FRONTIERS IN ONCOLOGY - -
Genome-wide profiling of patient-derived glioblastoma stem-like cells reveals recurrent genetic and transcriptomic signatures associated with brain tumors 2023 Lazzarini E.Romualdi C.Gallo A.Indraccolo S. + JOURNAL OF NEURO-ONCOLOGY - -
Quantification of Tumor and Angiogenesis-Related Markers in Ovarian Cancer Models by a Digital Pathology Approach 2023 Piga, IlariaMinuzzo, SoniaIndraccolo, Stefano + - METHODS IN MOLECULAR BIOLOGY Tumor Angiogenesis Assays
Anti-VEGF therapy selects for clones resistant to glucose starvation in ovarian cancer xenografts 2023 Tognon, MartinaCurtarello, MatteoMinuzzo, SoniaBrillo, ValentinaTrento, ChiaraRasola, AndreaBrisotto, GiuliaGrassi, AngelaIndraccolo, Stefano + JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH - -
Targeting NOTCH1 in combination with antimetabolite drugs prolongs life span in relapsed pediatric and adult T-acute lymphoblastic leukemia xenografts 2023 Minuzzo, SoniaAgnusdei, ValentinaPinazza, MaricaSerafin, ValentinaIndraccolo, Stefano + EXPERIMENTAL HEMATOLOGY & ONCOLOGY - -
Liquid Biopsy of Cerebrospinal Fluid Enables Selective Profiling of Glioma Molecular Subtypes at First Clinical Presentation 2023 Indraccolo S. + CLINICAL CANCER RESEARCH - -
Metabolic classification of non-small cell lung cancer patient-derived xenografts by a digital pathology approach: A pilot study 2023 Indraccolo, Stefano + FRONTIERS IN ONCOLOGY - -
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells 2022 Vittoria RaimondiLoredana UrsoBarbara BuldiniSamuela FrancescatoSonia A. MinuzzoStefano IndraccoloDonna M. D’AgostinoVincenzo Ciminale + REDOX BIOLOGY - -
EGFR T790M testing through repeated liquid biopsy over time: a real-world multicentric retrospective experience 2022 Dal Maso, ADel Bianco, PNardo, GZulato, EBonanno, LPasello, GIndraccolo, S + JOURNAL OF THORACIC DISEASE - -
Longitudinal liquid biopsy anticipates hyperprogression and early death in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors 2022 Del Bianco, PaolaBoscolo Bragadin, AndreaMarra, LudovicaPasello, GiuliaFassan, MatteoCalabrese, FiorellaGuarneri, ValentinaConte, Pier FrancoIndraccolo, StefanoBonanno, Laura + BRITISH JOURNAL OF CANCER - -
Liquid biopsy and non-small cell lung cancer: are we looking at the tip of the iceberg? 2022 Bonanno, LauraDal Maso, AlessandroZulato, ElisabettaPasello, GiuliaGuarneri, ValentinaConte, PierFrancoIndraccolo, Stefano + BRITISH JOURNAL OF CANCER - -
First-Line Osimertinib in Patients with EGFR-Mutant Advanced Non-Small Cell Lung Cancer: Outcome and Safety in the Real World: FLOWER Study 2021 Lorenzi, MartinaFerro, AlessandraScattolin, DanielaDal Maso, AlessandroIndraccolo, StefanoCalabrese, FiorellaBonanno, LauraConte, PierFrancoGuarneri, ValentinaPasello, Giulia + THE ONCOLOGIST - -
Detection of Low-Frequency KRAS Mutations in cfDNA From EGFR-Mutated NSCLC Patients After First-Line EGFR Tyrosine Kinase Inhibitors 2021 Marra, LudovicaBonanno, LauraBoscolo, AliceDal Maso, AlessandroBoscolo Bragadin, AndreaIndraccolo, StefanoZulato, Elisabetta + FRONTIERS IN ONCOLOGY - -
Druggable targets meet oncogenic drivers: opportunities and limitations of target-based classification of tumors and the role of Molecular Tumor Boards 2021 Indraccolo, SDel Re, MDei Tos, A PBonanno, LGuarneri, VConte, P + ESMO OPEN - -
A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib 2021 Santangelo A.Indraccolo S.Prandini P.DI Gennaro G.Caccese M.Zagonel V. + NEURO-ONCOLOGY - -
149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW) 2021 Lorenzi, M.Dal Maso, A.Ferro, A.Scattolin, D.Indraccolo, S.Frega, S.Menis, J.Bonanno, L.Guarneri, V.Conte, P. F.Pasello, G. + JOURNAL OF THORACIC ONCOLOGY - -
51P Liver kinase B1 (LKB1) and phosphorylated AMP kinase (AMPK) expression in small cell lung cancer (SCLC): Association with prognosis and tumour immune microenvironment (TIME) features 2021 Bonanno, L.Dal Maso, A.Zulato, E.Fassan, M.Pasello, G.Guarneri, V.Calabrese, F.Rea, F.Indraccolo, S.Conte, P. F. + JOURNAL OF THORACIC ONCOLOGY - -
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines 2021 Dal Maso, ALorenzi, MFerro, AScattolin, DIndraccolo, SFrega, SMenis, JBonanno, LCalabrese, FGuarneri, VConte, PPasello, G + FUTURE ONCOLOGY - -
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 2021 Urso L.Vernaci G.Fassan M.Zulato E.Faggioni G.Menichetti A.Di Liso E.Griguolo G.Conte P.Indraccolo S.Guarneri V.Dieci M. V. + FRONTIERS IN ONCOLOGY - -
SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia 2021 Minuzzo S.Indraccolo S. + LEUKEMIA - -
Mostrati risultati da 1 a 20 di 184
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile